JG
ACER

Jefferies Group’s Acer Therapeutics Inc ACER Stock Holding History

Jefferies Group’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-960
Closed -$35K – 3215
2015
Q2 		$35K Sell
960
-765
-44% -$29.4K ﹤0.01% 2527
2015
Q1 		$79K Buy
+1,725
New +$106K ﹤0.01% 1889

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return

Jefferies Group's ACER Position: Q3 2015 in Review

Jefferies Group sold out of Acer Therapeutics Inc (ACER) in Q3 2015, closing a stake of 960 shares — an estimated $35K sold.

Jefferies Group first reported a position in ACER in Q1 2015 and held it in 2 quarters. The position peaked at $79K in Q1 2015. 12 funds tracked by Wall St. Rank hold ACER as of Q3 2015.

  • Jefferies Group reported no remaining Acer Therapeutics Inc position as of Q3 2015 after selling out during the quarter.
  • Jefferies Group sold 960 Acer Therapeutics Inc shares in Q3 2015, an estimated $35K.
  • Jefferies Group first reported a position in Acer Therapeutics Inc in Q1 2015 and held it in 2 quarters.
  • Jefferies Group's Acer Therapeutics Inc position peaked at $79K in Q1 2015.
  • 12 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2015.

Based on Jefferies Group's 13F filing for Q3 2015, filed 13 Nov 2015.